Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02081027 · ClinicalTrials.gov registry record · Early Phase 1

Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders

A Early Phase 1 study of Autism Spectrum Disorders, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
Early Phase 1
Development phase
8
Enrollment target
1
Study location

NCT02081027 is a Early Phase 1 study of Autism Spectrum Disorders that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 8 participants, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02081027, a Early Phase 1 study of Autism Spectrum Disorders, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
Early Phase 1
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Determine if riluzole shows evidence of efficacy, safety, and tolerability targeting drug-refractory irritability (DRI) in persons with autism spectrum disorders (ASD).

Conditions Studied

Autism Spectrum Disorders

Interventions

  • OTHER placebo
  • DRUG Riluzole

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2013-09-19
Est. Completion 2015-05
Phase Early Phase 1

Sponsor

Children's Hospital Medical Center, Cincinnati

571 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02081027

The ClinicalTrials.gov registry entry for NCT02081027 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (95% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT02081027 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02081027 about?

NCT02081027 is a clinical study titled "Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders". Determine if riluzole shows evidence of efficacy, safety, and tolerability targeting drug-refractory irritability (DRI) in persons with autism spectrum disorders (ASD).

What is the current status of trial NCT02081027?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2013-09-19. Estimated completion is 2015-05.

What conditions does trial NCT02081027 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

What interventions are being tested in trial NCT02081027?

The interventions under investigation include: placebo (OTHER), Riluzole (DRUG).

Who is sponsoring clinical trial NCT02081027?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02081027 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorders

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.